Insight into Immune Checkpoint Inhibitor Therapy for Colorectal Cancer from the Perspective of Circadian Clocks

Scientists highlight the crosstalk between the tumor immune microenvironment in colorectal cancer (CRC) and the immunogenicity of CRC cells based on the circadian clocks.